ING3, a member of the inhibitor of growth (ING) family, has been reported to be involved in transcription modulation, cell cycle control and the induction of apoptosis. Previous studies have demonstrated that the expression of ING3 decreased in melanoma and head and neck squamous cell carcinoma (HNSCC). The aim of this study was to investigate the role of ING3 in hepatocellular carcinoma (HCC) tumorigenesis and progression. The correlation between ING3 expression and clinicopathological variables of HCC was analyzed. Using the real-time reverse transcription-polymerase chain reaction (RT-PCR), it was found that ING3 was downregulated in HCC tissues compared with adjacent non-cancerous tissues (p<0.05). The immunohistochemical staining of tissue microarray data indicated a significant reduction of ING3 expression in 57.14% of HCC cases (64/112). In addition, the downregulation of ING3 was associated with the tumor differentiation stage. Most HCC samples of Edmondson-Steiner grades II to III exhibited inhibition of ING3 expression. The overexpression of ING3 in HCC cells was found to suppress cell proliferation, colony formation and cell migration, suggesting that ING3 acts as a tumor suppressor in HCC cells. Taken together, the data revealed that ING3 may serve as a suppression factor during tumorigenesis and progression of HCC.
Introduction
The inhibitor of growth (ING) family of type II tumor suppressors comprises five conserved genes, ING1-5, which share 32-76% DNA sequence homology (1) (2) (3) (4) (5) (6) (7) . ING proteins contain a conserved plant homeodomain (PHD) in the C-terminal region, a nuclear localization signal (NLS) in the middle region and a novel conserved region (NCR) of unknown function at the N-terminus (8) . Results of previous studies showed that ING genes are involved in DNA repair, chromatin remodeling, cell cycle control, senescence and apoptosis (9, 10) .
The deregulation of ING genes was frequently detected in various types of cancer (9, 11) . ING1 gene expression was observed to be downregulated or lost in various types of cancer including breast, gastric, esophageal, lung and brain (2, (12) (13) (14) (15) (16) . Previous studies investigating ING2 in cancer have suggested that a reduction in expression is involved in the initiation of melanoma and the progression of hepatocellular carcinoma (HCC) (17, 18) . Certain studies have reported that ING4 expression was significantly suppressed in brain tumors, HCC, breast cancer and head and neck squamous cell carcinoma (HNSCC) (16, (19) (20) (21) . Our previous study also reported the decreased expression of ING5 gene in HCC (22) . Therefore, the deregulation of ING genes may contribute to tumorigenesis (8) .
The ING3 gene, which encodes a 46.8 kDa protein, has been associated with the modulation of p53-mediated transcription, cell cycle control and apoptosis (5) . Findings of previous studies demonstrated that the ectopic expression of ING3 in RKO cells decreased colony formation and the number of cells in the S phase. Although physical association with p53 is required for the function of the other ING members, ING3 does not appear to interact with p53 (8) . In melanoma cells, ING3 overexpression promotes UV-induced apoptosis through a Fas/caspase-8-dependent pathway in a p53-independent manner (23) . ING3 has been reported to be a tumor suppressor in melanoma and HNSCC (24, 25) . Low levels of ING3 mRNA may indicate an aggressive head and neck carcinoma. In melanoma, ING3 nuclear expression is reduced and may be an independent prognostic factor (21) .
In this study, the expression of ING3 was evaluated in tissues at different stages of HCC using the reverse transcription-polymerase chain reaction (RT-PCR) and an immunohistochemical assay of tissue microarray (TMA). ING3 was significantly downregulated in malignant HCC tissue. Moreover, it was demonstrated that ING3 suppressed HCC cell proliferation, colony formation and inhibited cell migration. This suggests that the deregulation of ING3 is involved in the tumorigenesis and metastasis of HCC.
Materials and methods
Tissue specimens and cell lines. The tumor and normal liver specimens were obtained from patients who had provided informed consent. HepG2, Hep3B, Huh7, Bel-7402, Bel-7404,  Bel-7405, PLC, PCL/PRF/5, LM3, LM6, QCY-7701, SNU398,  MHCC-H, MHCC-L, YY-8103, SK-HEP, SMMC-7721 and Focus were the 18 liver tumor-derived cell lines used in this study. The study and the protocol for the use of human tissues for this study were approved by the ethics committee of the Chinese National Human Genome Center (Shanghai, China). Immunohistochemical analysis. Slides containing 121 HCC specimens with adjacent noncancerous tissues (Shanghai Biochip Company Ltd., Shanghai, China) were used to evaluate ING3 expression via immunohistochemistry. The slides were incubated overnight at 4˚C with rabbit anti-ING3 polyclonal antibody (1:200 dilution), followed by incubation with a horseradish peroxidase-conjugated anti-rabbit secondary antibody (Dako Japan Ltd., Kyoto, Japan) at 37˚C for 30 min. Normal rabbit IgG was used as a negative control. The signals were visualized using 3,3'-diaminobenzidine tetrahydrochloride (DAB). The slides were counterstained with hematoxylin, dehydrated through gradient alcohols and mounted for observation. The total ING3 immunostaining was calculated as the sum of the relative positivity of stained tumor cells and the staining intensity. The relative positivity was scored as weakly, moderately and strongly stained. The final ING3 expression levels were defined as: 'upregulated', 'equal' and 'downregulated' in HCC samples compared with noncancerous livers.
Cell culture and transfection. Cell lines were cultured in DMEM-high supplemented with 10% fetal bovine serum (Gibco, Carlsbad, CA, USA) in a 5% CO 2 atmosphere at 37˚C. The expression vector pcDNA3.0 and the pcDNA3.0-ING3 plasmids were transfected by lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions.
Cell proliferation and colony formation. To observe cell proliferation, the Hep3B cells transfected with ING3 were seeded in 96-well plates at 3,000 cells/well and cultured for 6 days. Cell viability was measured using the Cell Counting Kit-8 (Dojindo Laboratories, Kunamoto, Japan). HCC cells transfected with pcDNA3.0-ING3 were cultured on 100-mm plates and selected with G418 (Life Technologies, Inc., Carlsbad, CA, USA) at a final concentration of 0.6 to 1 mg/ml for colony formation.
Wound-healing assay. The transfected cells were plated in 60-mm dishes at the same density, scratch wounded with a micropipette tip, washed to remove detached cells, provided with fresh medium including 2% FBS and were incubated at 37˚C during image capture. The wounds were marked under the dish with a felt tip pen and images were captured at these sites using a x10 objective at 0 h and again at 24 and 48 h. Cell motility was evaluated using the formula: Wound closure = (distance 24 or 48 h -distance 0 h )/distance 0 h .
Western blot analysis. Following transfection, the cells were obtained via lysis buffer [25 mmol/l Tris (pH 6.8), 1% SDS, 5 mmol/l EDTA, protease inhibitor cocktail (Sigma)]. The protein samples were resolved via SDS-PAGE and transferred onto a nitrocellulose membrane which was blocked in 5% skimmed milk in phosphate-buffered saline (PBS) containing Tween (PBS-Tween) and probed with the indicated antibodies. The membrane was scanned on an Odyssey infrared imaging system (LI-COR) at a wavelength of 700 or 800 nm. Rabbit anti-ING3 and mouse anti-β-actin (Sigma) antibodies were used in this study.
Statistical analysis.
Quantitative values are shown as the mean ± standard deviation (SD) or median (range). A paired samples t-test was used to determine the difference between HCC and noncancerous livers. A χ 2 test was performed to analyze the correlation between ING3 expression and various clinicopathological characteristics. The SPSS (Chicago, IL, USA) 13.0 software was used for all statistical analyses. P<0.05 was considered to indicate a statistically significant result.
Results

Decreased expression of ING3 in HCC.
Previous studies have suggested that most members of the ING family, including ING1, ING2, ING4 and ING5, are downregulated in HCC (16, 18, 26, 27) . In the present study, the relative expression levels of ING1-5 were investigated in 18 pairs of human HCC specimens by real-time RT-PCR and it was observed that the mRNA levels of the five ING family members were significantly downregulated in HCC tumor tissues (22) . To understand the correlation of ING3 expression with HCC, the mRNA expression level of ING3 in an additional 31 human HCC specimens was observed. ING3 was markedly downregulated in all 49 tumor tissues compared with adjacent noncancerous livers (Fig. 1A) . The semiquantitative RT-PCR of 3 pairs of randomly selected human HCC specimens confirmed the observation of a decreased ING3 expression in HCC tissues (Fig. 1B) . The corresponding mRNA expression in 18 typical HCC cell lines was also examined by RT-PCR (Fig. 1C) . The cultured HCC cells expressed various levels of ING3, which were lower than those of normal liver tissue.
Immunohistochemistry and clinicopathological analysis.
To investigate the ING3 protein expression in human HCC tissues, a tissue array containing 112 pairs of HCC specimens was examined by immunohistochemical staining with an ING3 antibody (Fig. 2) . The expression of the ING3 protein was downregulated in 57.14% (64/112) HCC tissues compared with the corresponding noncancerous livers, while the upregulation of ING3 was detected in 21.42% (24/112) samples of HCC and the remaining 24 HCC tissues exhibited almost the same level of ING3 expression (Table Ⅰ) . To understand the correlation of ING3 levels with clinicopathological features, the χ 2 test was used to analyze the correlations between the staining intensity of the ING3 protein and the clinicopathological variables of HCC (Table Ⅰ) . The ING3 protein staining intensity showed no significant correlation with gender or age (p>0.05; Table Ⅰ ). However, the downregulation ratio of the ING3 protein was significantly greater in the HCC samples with Edmondson-Steiner grades II/III than in those with Edmondson-Steiner grades Ⅰ/II (Table Ⅰ; p=0.004), suggesting that a low expression level of ING3 in HCC is associated with tumor differentiation and classification. (Fig. 3A) . The tumor cell growth was examined daily for 6 days using the CCK-8 assay and the ability to form 
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colonies was measured following the treatment of the cells with G418. As shown in Fig. 3B , the overexpression of ING3 significantly suppressed cell proliferation of Hep3B cells (p<0.05). In addition, the colony formation was also markedly inhibited by ING3 in Hep3B cells ( Fig. 3C; p<0 .01). In Huh7 cells, although no effect on the cell proliferation was detected (data not shown), ING3 greatly decreased the colony formation ( Fig. 3D; p<0 .05). These data suggest that as a tumor suppressor, ING3 inhibited the hepatoma cell growth in vitro.
ING4 inhibits hepatoma cell migration. Cell motility plays a significant role during tumor progression and tumor metastasis. The present study also showed that the downregulation of ING3 was correlated with the grade of HCC. The effect of ING3 on hepatoma cell migration was then investigated using the wound-healing assay. The Hep3B and Huh7 cells with ING3 overexpression were scratched and monitored for wound healing with time. Notably, the hepatoma cells in which ING3 was overexpressed migrated markedly slower than the control cells ( Fig. 4A and B) . The wound healing rate of the Hep3B and Huh7 cells was significantly decreased by ING3 overexpression (Fig. 4C and D, p<0 .05). These data indicate that ING3 impaired the migration ability of hepatoma cells, implying that ING3 plays an inhibitory role in HCC metastasis.
Discussion
The ING family members are type II tumor suppressor genes and have been reported to be involved in multiple cell processes, including cell growth and proliferation, senescence, DNA repair, oncogenesis, apoptosis, angiogenesis and tumorigen-esis (8, 9) . Previous studies have indicated that the ING family is involved in HCC pathogenesis. The expression of ING1 variants was markedly reduced in HCC samples. ING1 inhibited the hepatoma cell growth via stabilization and activation of p53 by interacting with Mdm2 and p14ARF (26, 27) . As a candidate tumor suppressor gene, ING2 was involved in the progression of HCC (18) . The downregulation of ING2 has been observed in 52.8% of HCC and is associated with tumor size, histopathological classification and serum α-fetoprotein. Similarly, ING4 expression was found to be significantly reduced in HCC and the expression level also correlated with patient prognosis and the metastatic potential of HCC (16) . In a recent study, we reported that the suppression of ING5 was correlated with the progression of HCC (22 (23) . In the present study, cell proliferation, colony formation and wound-healing assays were performed to investigate the functional role of ING3 in HCC cells. The ectopic expression of ING3 in Hep3B and Huh7 cells inhibited colony formation and cell migration significantly, suggesting that ING3 is involved in tumorigenesis and metastasis. These findings were consistent with the immunohistochemical staining and tissue array results. However, the cell proliferation results of these HCC cells demonstrated a different effect of ING3. Overexpression of ING3 suppressed the cellular growth in Hep3B cells but not in Huh7 cells, suggesting that the cellular inhibitory effect of ING3 in HCC depends on various mechanisms.
Previous studies have suggested that ING3 was downregulated in HSNCC and may play a suppressing role in melanoma tumorigenesis. The degradation of ING3 protein by SCF-mediated ubiquitin-proteasome system in melanoma results in progression of the tumor (28) . Another study showed that the nuclear-to-cytoplasmic translocation of ING3 resulted in a decreased nuclear expression and was involved in melanoma initiation and tumor progression (25) . However, the potential role of ING3 as a tumor suppressor in other types of cancer remains unclear. In this study, downregulation of ING3 was found to be correlated with tumorigenesis and the progression of HCC. Moreover, ING3 may inhibit the tumorigenesis through suppressing cell proliferation and colony formation. Furthermore, ING3 may impede tumor metastasis by inhibiting cell migration. The role played by the molecular mechanism of ING3 in the suppression of HCC requires further clarification; however, the present study indicated that ING3 is a potential therapeutic target of HCC. The function of ING3 in HCC tumorigenesis and progression therefore merits further investigation.
